Skip to content

ANXIETY AND DEPRESSION DURING COVID-19 IN INDIA

PREVALENCE OF SYMPTOMS OF ANXIETY AND DEPRESSION DURING COVID-19 IN INDIA: A WEB-BASED CROSS-SECTIONAL STUDY

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/04/024784
Enrollment
1000
Registered
2020-04-22
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Dr Sameer Malhotra SELF SPONSORED NO CONFLICT OF INTEREST
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Participants of the age of 18 years and above Participants residing in India Participants with minimum 10 years of education with basic knowledge of English

Exclusion criteria

Exclusion criteria: Participants under the age of 18 years Participants residing outside of India  Participants with previous history of any major psychiatric illness, psychiatric hospitalization or currently on any psychiatric medication.Â

Design outcomes

Primary

MeasureTime frame
To understand the prevalence (magnitude) of depression and anxiety of general adult population during COVID-19 using Generalized Anxiety Disorder Scale (GAD-7) and Patient Health Questionnaire (PHQ-9). Rise in Anxiety and Depression will be noted. Timepoint: 1 month during the period of COVID-19 pandemic.

Secondary

MeasureTime frame
Through the analysis of the results, it will help device psychological intervention/mental health programs geared towards general and specific symptoms and management of emotional needs can be provided to the general population during and post-crisis.Timepoint: 1 month during the period of COVID-19 pandemic.

Countries

India

Contacts

Public ContactShreya Singhal

Max Super Speciality Hospital, Saket, New Delhi

singhal.shreya21@gmail.com9810022980

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026